Mucosal Origin and Shedding of an Early Colonic Tumor Marker Defined by Adnab-9 Monoclonal Antibody

References

• Freed D LJ, Taylor G. Carcinoembryonic antigen in faeces. Br Med J 1972; 1: 85–7
   PubMed Web of Science ®Google Scholar
• Elias E G, Holyoke E D, Chu T M. Carcinoembryonic antigen in feces and plasma of normal subjects and patients with colorectal carcinoma. Dis Col Rect 1974; 17: 38–41
   PubMed Web of Science ®Google Scholar
• Winawer S J, Groom G, Green S. Carcinoembryonic antigen in colonic lavage. Gastroenterology 1977; 73: 719–22
   PubMed Web of Science ®Google Scholar
• Velacott K D, Groom G, Balfour T W. Tumor associated products in colonic lavage fluid. Clin Oncol 1982; 8: 61–7
   PubMed Web of Science ®Google Scholar
• Stubbs R S, Nadkami D M, Monsey H A. Faecal carcinoembryonic antigen in colorectal cancer patients. Gut 1986; 27: 901–5
   PubMed Web of Science ®Google Scholar
• Fujimoto S, Kitsukawa Y, Itoh K. Carcinoembryonic antigen (CEA) in gastric juice or feces as an aid in the diagnosis of gastrointestinal cancer. Ann Surg 1979; 189: 34–8
   PubMed Web of Science ®Google Scholar
• Rozen P, Tobi M, Darmon E, Kaufman L. Colonic cytology: a simplified method of collection and initial results. Acta Cytol 1990; 34: 627–31
   PubMed Web of Science ®Google Scholar
• Darmon E, Tobi M, Rozen P. Newer tests, on the colonic effluent, for identifying persons with colorectal neoplasia. Advances in large bowel cancer: policy, prevention and treatment, P Rozen, C B Reich, S J Winawer. Front Gas-trointest Res, 1991; 18: 236–47
   Google Scholar
• Tobi M, Darmon E, Phillips T. Increased expression of a putative adenoma associated antigen in precolonoscopic effluent of patients with colorectal cancer. Cancer Lett 1990; 50: 21–5
   Web of Science ®Google Scholar
• Tobi M, Steinberg W, Henry J, Nochomovitz L. Cancer associated CA19–9 in colonic effluent of patients with neoplasia of the colon and inflammatory bowel disease. Cancer Lett 1991; 60: 9–13
   PubMed Web of Science ®Google Scholar
• Gordon I L, Rypins E B, Jakowatz J J. Cytologic detection of colorectal cancer after administration of oral lavage solution. Cancer 1991; 68: 106–10
   PubMed Web of Science ®Google Scholar
• Iyengar V, Albaugh G P, Lohani A, Nair P P. Human stools as a source of viable colonic epithelial cells. FASEB J 1991; 5: 2856–9
   PubMed Web of Science ®Google Scholar
• Sidransky D, Tokino T, Hamilton S R. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992; 256: 102–5
   PubMed Web of Science ®Google Scholar
• Rozen P. Screening for colorectal neoplasia in the Tel Aviv area: cumulative data 1979-1989 and initial conclusions. Isr J Med Sci 1992; 28(Suppl)8–20
   PubMedGoogle Scholar
• Gaspari M M, Brennan P T, Solomon S M, Elson C O. A method of obtaining, processing, and analyzing human intestinal secretions for antibody content. J Immunol Methods 1988; 100: 85–91
   Google Scholar
• O'Mahony S, Barton J R, Crichton S, Ferguson A. Appraisal of gut lavage in the study of intestinal humoral immunity. Gut 1990; 31: 1341–4
   PubMed Web of Science ®Google Scholar
• Tobi M., O'Kieffe D, Trujillo N, Nochomovitz L E, Steinberg W. Detection of carcinoembryonic antigen in colonic effluent by specific anti-CEA antibodies. Cancer Lett 1992; 67: 737–42
   Web of Science ®Google Scholar
• Tobi M, Darmon E, Rozen P. Oral colon lavage solutions may interfere with ELISA detection of tumor association antigens in colonic effluent. Dig Dis Sci 1991; 36: 1448–52
   PubMed Web of Science ®Google Scholar
• Tobi M, Maliakkal B J, Alousi M A. Cellular distribution of a colonic adenoma-associated antigen as defined by monoclonal antibody Adnab-9. Scand J Gastroenterol 1992; 27: 737–42
   PubMed Web of Science ®Google Scholar
• Tobi M, Kaila V, Goo R. An adenoma-associated antigen as a preneoplastic marker in familial polyposis coli versus sporadic colonic neoplasia. Gastroenterology 1992; 102: A403
   PubMed Web of Science ®Google Scholar
• Tobi M, Maliakkal B J, Zitron I. Colonic effluent adenoma-associated antigen correlated with colorectal cancer in a membrane-bound glycoprotein. Cancer Lett 1992; 67: 61–9
   PubMed Web of Science ®Google Scholar
• Lowry O H, Rosenbrough N J, Farr A L, Randall R J. Protein measurements with folin phenol reagent. J Biol Chem 1951; 193: 265–75
   PubMed Web of Science ®Google Scholar
• Luk G D, Yang P. Distribution of polyamines and their biosynthetic enzymes in intestinal adaptation. Am J Phys 1988; 254: G194–200
   Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4
   PubMed Web of Science ®Google Scholar
• Laemmli V K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–5
   PubMed Web of Science ®Google Scholar
• Primus F J, Freeman J W, Goldenberg D M. Immunological heterogeneity of carcinoembryonic antigen: purification from meconium of an antigen related to carcinoembryonic antigen. Cancer Res 1983; 43: 679–85
   PubMed Web of Science ®Google Scholar
• Fink A, Harpaz N., Weizman Z. The isolation of colon cancer organ specific neoantigen by the use of leucocyte adherence inhibition assay and monoclonal antibodies. Anticancer Res 1986; 6: 813–8
   PubMed Web of Science ®Google Scholar
• Tobi M, Chintalapani S, Kaila V, Halline A, Fink A, Bentwich Z. Diagnosis of colorectal cancer (CRC) by monoclonal antibodies (MAbs) tailored for detection in bodily fluids. Proc Am Assoc Cancer Res 1992; 33: 96
   Google Scholar
• Thomas P., Toth C A. Carcinoembryonic antigen binding to Kupffer cells is via a peptide located at the junction of the N-terminal and first loop domain. Biochem Biophys Res Commun 1990; 170: 391–6
   PubMed Web of Science ®Google Scholar
• Deutsch M A., Pence J C, Kerns B-JM. Detection of a novel manner in the bronchial secretions of patients with non-small cell lung cancer (NSCLC) using the 4B5 monoclonal antibody. Cancer 1992; 69: 2894–904
   PubMed Web of Science ®Google Scholar
• Silverberg E, Lubera J. Cancer statistics CA 1988; 38: 16–7
   Google Scholar
• Pence J C., Deutsch M A, Kerns B-JM. Sensitive and specific detection of the 4B5 antigen in bronchial lavage specimens from patients with primary bronchogenic carcinoma. Cancer 1992; 70: 1115–23
   PubMed Web of Science ®Google Scholar
• Whiteman P. The quantitative determination of glycoam-inoglycans in urine with Alcian Blue 8GX. Biochem J 1973; 131: 351–7
   PubMed Web of Science ®Google Scholar
• Hall R L, Miller R J, Peatfield A G, Richardson P S, Williams L, Lampert I. A colorimetric test for mucous glycoproteins using Alcian Blue. Biochem Soc Trans 1980; 8: 72
   PubMedGoogle Scholar
• Mathematical models in medicine. Part 1, D Ingram, R Bloch. John Wiley & Sons, New York 1984
   Google Scholar
• Tobi M, Kaila V, Ali M Z. An antigenic profile of adenocarcinoma of the small bowel (ASB): Evidence for an adenoma-carcinoma sequence. Proc Am Assoc Can Res 1992; 33: 96
   Google Scholar
• Nap M, Mollgard K, Burtin P, Fleuren G J. Immunohisto-chemistry of carcinoembryonic antigen in the embryo, fetus and adult. Tumor Biol 1988; 9: 145–153
   PubMedGoogle Scholar
• Creamer B. Paneth cell function. Lancet 1967; 1: 314–6
   PubMed Web of Science ®Google Scholar
• Symonds D A. Paneth cell metaplasia in diseases of the colon and rectum. Arch Pathol 1974; 97: 343–7
   PubMedGoogle Scholar
• Dick W, Schwandner G. Klinische Bedeutung des Lysozyms bei kolorektalen Tumoren. MMW 1982; 124: 619–20
   Google Scholar
• Costongs G MPJ, Hemrika M H, Engels L GJB. Faecal lysozyme: determination, reference intervals and some data in gastrointestinal disease. Clin Chim Acta 1987; 125: 125–34
   Google Scholar
• Terpstra O T, van-Blankenstein M, Dees J, Eilers G A. Abnormal patterns of cell proliferation in the entire colonic mucosa of patients with colonic adenoma or cancer. Gastroenterology 1987; 92: 704–8
   PubMed Web of Science ®Google Scholar
• Shamsuddin A M, Elsayed A M. A test for the detection of colorectal cancer. Hum Pathol 1988; 19: 7–20
   PubMed Web of Science ®Google Scholar
• Frommer D J, Kapparis A, Brown M K. Improved screening for colorectal cancer by immunological detection of occult blood. Br Med J 1988; 296: 1092–4
   PubMed Web of Science ®Google Scholar
• Nakayama T, Yasuoka H, Kishino T, Ohguchi H, Takada M. ELISA for occult faecal albumin. Lancet 1987; 1: 1368–9
   PubMed Web of Science ®Google Scholar
• Simon J B. Occult blood screening for colorectal cancer: a critical review. Gastroenterology 1985; 88: 820–37
   PubMed Web of Science ®Google Scholar
• Borriello S P. Microbial flora of the gastrointestinal tract. Microbial metabolism in the digestive tract, M J Hill. CRC Press, Boca Raton, FL 1986; 1–19
   Google Scholar
• Wagener C, Muller-Wailraf R, Nisson S, Groner J, Breuer H. Localization and concentration of carcinoembryonic antigen (CEA) in gastrointestinal tumors: correlation with CEA levels in plasma. J Natl Can Inst 1981; 67: 539–47
   PubMedGoogle Scholar
• Yuan M, Itzkowitz S H, Palekar A. Distribution of blood group antigens A, B, H, Lewis3 and Lewisb in human normal, fetal and malignant colonic tissue. Cancer Res 1985; 45: 4499–511
   PubMed Web of Science ®Google Scholar